Peak Bio Statistics
Total Valuation
Peak Bio has a market cap or net worth of 4.16 million. The enterprise value is 16.22 million.
| Market Cap | 4.16M |
| Enterprise Value | 16.22M |
Important Dates
The next estimated earnings date is Friday, November 22, 2024.
| Earnings Date | Nov 22, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Peak Bio has 23.12 million shares outstanding. The number of shares has increased by 18.70% in one year.
| Shares Outstanding | 23.12M |
| Shares Change (YoY) | +18.70% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 40.04% |
| Owned by Institutions (%) | 1.78% |
| Float | 10.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.55 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.51 |
| EV / Sales | 45.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.06
| Current Ratio | 0.06 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.78 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -262.11% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 59,004 |
| Profits Per Employee | -771,238 |
| Employee Count | 6 |
| Asset Turnover | 0.22 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.18% in the last 52 weeks. The beta is 0.22, so Peak Bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -18.18% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.41 |
| Relative Strength Index (RSI) | 63.73 |
| Average Volume (20 Days) | 5,989 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, Peak Bio had revenue of 354,023 and -4.63 million in losses. Loss per share was -0.20.
| Revenue | 354,023 |
| Gross Profit | -368,018 |
| Operating Income | -6.77M |
| Pretax Income | -4.63M |
| Net Income | -4.63M |
| EBITDA | -6.65M |
| EBIT | -6.77M |
| Loss Per Share | -0.20 |
Balance Sheet
The company has 235,774 in cash and 12.30 million in debt, giving a net cash position of -12.06 million or -0.52 per share.
| Cash & Cash Equivalents | 235,774 |
| Total Debt | 12.30M |
| Net Cash | -12.06M |
| Net Cash Per Share | -0.52 |
| Equity (Book Value) | -22.59M |
| Book Value Per Share | -0.98 |
| Working Capital | -22.69M |
Cash Flow
| Operating Cash Flow | -4.41M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -103.95% |
| Operating Margin | -1,913.08% |
| Pretax Margin | -1,307.10% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Peak Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.70% |
| Shareholder Yield | -18.70% |
| Earnings Yield | -113.18% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Peak Bio has an Altman Z-Score of -75.8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -75.8 |
| Piotroski F-Score | n/a |